跳至主要内容
临床试验/NL-OMON41598
NL-OMON41598招募中3 期

aser therapy for onychomycosis in patients with diabetes at risk for diabetic foot complications A randomized, double blind controlled trial. - LASER-1

Isala Klinieken0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • known diabetes (type 1 or 2)
  • over 18 years old
  • clinically suspicion with microbiologic confirmation of onychomycosis
  • at risk for diabetic foot ulcers defined by a Simm*s score 1 or 2
  • the nail has to be involved for at least 25% .

排除标准

  • patients without microbiologic confirmation of fungal nail infection
  • patients with diabetic foot ulcers or foot ulcer in the medical history
  • patients who used systemic or topical antifungal agents during the preceding 3 months
  • patients with insufficient knowledge of the Dutch language to understand the requirements of the study
  • patients who use immunosuppressive medication will also be excluded.
  • patients suffering from psoriasis with nail involvement, lichen planus, or other abnormalities that could result in clinically abnormal toenails will be excluded.
  • patients with an ankle brachial index <0.9 and/or toepressure <50 mmHg
  • patients with ischaemic rest pain.
  • Patients with severe renal failure (eGFR<30 ml/min) or dialysis.

研究者

发起方
Isala Klinieken

相似试验